Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Nelipak picks up thermoformer Tegrant Alloyd Brands from Sonoco
Nelipak said today that it acquired a thermoforming company in Puerto Rico, Tegrant Alloyd Brands, from Sonoco for an undisclosed amount. Read more
4. Study: St. Jude Medical’s CardioMEMS lowers all-cause admissions in HF patients
Use of St. Jude Medical‘s CardioMEMS implantable heart monitor in patients previously hospitalized for heart failure can significantly reduces all-cause heart failure admissions, according to data from a new study released late last month.
Data from an oral abstract of the study was presented at the 12th Annual AAHFN meeting, according to a report from Healio. Read more
3. Private equity shop RoundTable Healthcare closes $140m Symmetry Surgical buy
RoundTable Healthcare Partners said this week that it closed the $140.3 million buyout of Symmetry Surgical, the legacy business formed after Symmetry Medical sold its orthopedics OEM operation to Tecomet in 2014.
Nashville-based Symmetry Surgical makes reusable, reposable and single-use surgical instrumentation and specialty devices. The Lake Forest, Ill.-based private equity shop said it plans to leave president & CEO Thomas Sullivan in charge of Symmetry Surgical and named senior operating partner Thomas Kapfer as chairman. Read more
2. Senseonics takes out $30m term loan
Senseonics said yesterday that it took out a term loan worth $30 million from Oxford Finance and Silicon Valley Bank, augmenting the $45 million it raised in an initial public offering in March.
Germantown, Md.-based Senseonics, which makes the Eversense implantable continuous glucose monitor, said it used $11 million of the 1st, $15 million withdrawal to pay off existing loans from Oxford. The remaining $15 million can be drawn down through the end of 2017 after the company reaches unspecified milestones, Senseonics said. Read more
1. QT Vascular wins CE Mark for Chocolate Heart DCB
QT Vascular said today that it won CE Mark approval in the European Union for its Chocolate Heart drug-coated balloon for treating coronary artery disease.
The Chocolate Heart device is a paclitaxel-coated version of the Chocolate balloon that won FDA approval back in June 2014, the Singapore-based company said. Read more
The post MassDevice.com +5 | The top 5 medtech stories for July 7, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/29zOHwP
Cap comentari:
Publica un comentari a l'entrada